22
Jan
2025

LTS Lohmann Therapie Systeme AG

Exhibitor at Pharmapack Europe 2025 stand H33
About Us

We CARE. We CREATE. We DELIVER. The driving philosophy behind LTS LOHMANN Therapie-Systeme AG. As a trusted technology partner for the pharmaceutical industry, we develop and manufacture innovative drug delivery systems such as Transdermal Patches (“TTS”) and Oral Thin Films (“OTF”) as well as wearable drug delivery devices (“OBDS”). LTS´ commercial offering encompasses more than 20 marketed products and a diverse pipeline of more than 40 development projects targeting multiple disease indications. 

  • IL
  • 2022
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Drug delivery device Supplier/Manufacturer
Primary activities
Medical Devices
Contact info
  • 29 Yad Harutzim St., 4250529, Netanya, Israel
Event information
Pharmapack Europe 2025
  • 22 Jan 2025 - 23 Jan 2025
  • Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
  • Visit us at stand H33

Products Featured at Pharmapack Europe 2025

  • Sorrel Wearable Drug Delivery Platform

    Product Sorrel Wearable Drug Delivery Platform

    Sorrel wearable drug delivery platform provides a patient-centric and partner-focused solution designed for the simple and efficient administration of large volume and high viscosity medications. Intuitive and easy to use, Sorrel’s wearable device arrives to the patient ready to use, pre-filled and pre-loa...
  • Sorrel™ Drug Delivery Platform

    Product Sorrel™ Drug Delivery Platform

    Sorrel’s technological flexibility, coupled by our total market approach, strike the perfect balance between what is best for the patients and what is optimal for pharma companies
    Based on our high-end patents and groundbreaking design, Sorrel is suited for multiple configurations, molecules, and indi...
  • Micro Array Patches (MAP)

    Product Micro Array Patches (MAP)

    MAP – TRANSDERMAL”NEXT BIG THING”TRANSDERMAL

    Empowering your next-gen molecules, now.

    Micro Array Patches (MAP) from LTS are designed to enhance delivery through the intradermal route delivering a wide range of APIs including biologics and vaccines. As an innovative dosag...